Home Healthcare Biotechnology Lymphedema Diagnostics Market

Lymphedema Diagnostics Market Size, Share & Trends Analysis Report By Technology (Lymphoscintigraphy, MRI, Ultrasound, Near IR Fluorescence Imaging), By Disease Type (Cancer, Inflammatory Disease, Cardiovascular, Filariasis), By End User (Hospitals, Diagnostic Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Lymphedema Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Lymphoscintigraphy
    2. MRI
    3. Ultrasound
    4. Near IR Fluorescence Imaging
  2. Lymphedema Diagnostics Market, By Disease Type  2022-2034 (USD MILLION/ Units)
    1. Cancer
    2. Inflammatory Disease
    3. Cardiovascular
    4. Filariasis
  3. Lymphedema Diagnostics Market, By End User 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Diagnostic Centers
  4. Regional Lymphedema Diagnostics Market
    1. North America
      1. North America Lymphedema Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
      2. North America Lymphedema Diagnostics Market By Disease Type  2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Inflammatory Disease
        3. Cardiovascular
        4. Filariasis
      3. North America Lymphedema Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
      4. U.S.
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      5. Canada
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
    2. Europe
      1. Europe Lymphedema Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
      2. Europe Lymphedema Diagnostics Market By Disease Type  2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Inflammatory Disease
        3. Cardiovascular
        4. Filariasis
      3. Europe Lymphedema Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
      4. U.K.
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      5. Germany
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      6. France
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      7. Spain
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      8. Italy
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      9. Russia
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      10. Nordic
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      11. Benelux
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      12. Rest of Europe
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
    3. APAC
      1. APAC Lymphedema Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
      2. APAC Lymphedema Diagnostics Market By Disease Type  2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Inflammatory Disease
        3. Cardiovascular
        4. Filariasis
      3. APAC Lymphedema Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
      4. China
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      5. Korea
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      6. Japan
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      7. India
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      8. Australia
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      9. Singapore
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      10. Taiwan
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      11. South East Asia
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      12. Rest of Asia-Pacific
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
    4. Middle East and Africa
      1. Middle East and Africa Lymphedema Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
      2. Middle East and Africa Lymphedema Diagnostics Market By Disease Type  2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Inflammatory Disease
        3. Cardiovascular
        4. Filariasis
      3. Middle East and Africa Lymphedema Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
      4. UAE
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      5. Turkey
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      6. Saudi Arabia
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      7. South Africa
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      8. Egypt
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      9. Nigeria
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      10. Rest of MEA
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
    5. LATAM
      1. LATAM Lymphedema Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
      2. LATAM Lymphedema Diagnostics Market By Disease Type  2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Inflammatory Disease
        3. Cardiovascular
        4. Filariasis
      3. LATAM Lymphedema Diagnostics Market By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Diagnostic Centers
      4. Brazil
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      5. Mexico
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      6. Argentina
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      7. Chile
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      8. Colombia
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
      9. Rest of LATAM
        1. Lymphoscintigraphy
        2. MRI
        3. Ultrasound
        4. Near IR Fluorescence Imaging
        5. Cancer
        6. Inflammatory Disease
        7. Cardiovascular
        8. Filariasis
        9. Hospitals
        10. Diagnostic Centers
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.